Ardena, a contract development and manufacturing organization (CDMO) specializing in bringing molecules to clinic, has been granted a good manufacturing practice (GMP) license by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its state-of-the-art aseptic fill-finish facility in Ghent, Belgium. The company now has capacity for large molecule biologics, including proteins, next to oligonucleotides (DNA, recombinant RNA, synthetic RNA, RNA vaccines) and peptides. In ...